Women are still facing barriers accessing certain cancer treatments and testing in some parts of Victoria. Last week, Monash Partners Comprehensive Cancer Consortium (MPCCC) together with Monash Biomedicine Discovery Institute (BDI) brought together a powerhouse panel to discuss equity issues this International Women’s Day. The panel discussion, titled "Women's Health [...]
We are proud to be kicking off 2023 with a bang, by announcing the launch of our new logo, and refreshed colours, as part of the ongoing growth and transformation of our consortium. Just over this past 12 months we have seen significant changes such as; Appointed our Co-Directors, Prof [...]
It’s been a complex year. As I write, the community is preparing for a festive season free of the restrictions we have had to navigate in recent years, yet these freedoms are associated with a fourth COVID-19 wave, continuing pressures in our hospitals and healthcare systems, workforce shortages and ongoing [...]
A new study led by Monash Health and Monash University researchers has uncovered important insights to explain COVID19 vaccine hesitancy amongst people with solid cancers, and recommended practical solutions to better inform and support patients. Dr Nathan Bain and Dr Mike Nguyen co-led a recently published paper in online journal, [...]
A big congratulations to Trang Tran on being awarded the MPCCC precision medicine scholarship! Trang is currently doing her PhD in the Hormone Cancer Therapeutics laboratory at the Hudson Institute, headed by Dr. Simon Chu. “My interests lie in understanding the molecular mechanisms involved in the pathogenesis of ovarian granulosa [...]
An Australian collaboration led by researchers at Monash Health and Monash University has developed and validated a new tool, and used it to assess how people with chronic diseases, including cancer, feel about the COVID-19 vaccine. The large study was conducted across 9 Australian health services during the national COVID-19 [...]
The MPCCC is committed to ensuring that we proactively engage and involve people affected by cancer in all of our research and clinical improvement programs and associated activities. A new opportunity is now open for two enthusiastic change agents, who have experience with cancer as a patient and/or carer, to [...]
2021 has been a progressive year for the MPCCC, despite the challenges of social isolation and rapidly changing circumstances for our healthcare providers and patients. We have achieved $7.5m funding to further develop the MPCCC and its research and education programs over the next four years, thanks [...]
People being treated for cancer in Gippsland can now participate in clinical trials at Monash Health, opening up new therapeutic options that have not previously been available. Supported by funding from the Victorian Government, a new telehealth clinic has been introduced to match patients living in Gippsland with oncology clinical [...]
Monash Health researchers are working with collaborators across Australia on a new clinical trial that will investigate the response of COVID-19 vaccines in people with cancer. The SerOzNET study will examine serological and immunological responses to COVID-19 vaccinations administered to Australian adults with cancer. Funded by Cancer Australia, SerOzNET will contribute [...]
